Meeting
2014 Genitourinary Cancers Symposium
Utility of multiparametric MRI at 3 tesla and MRI/ultrasound fusion-guided biopsy in detecting seminal vesicle invasion by prostate cancer.
Authors
Dima Raskolnikov
Urologic Oncology Branch, National Cancer Institute at the National Institutes of Health, Bethesda, MD
Dima Raskolnikov , Soroush Rais-Bahrami , Arvin George , Baris Turkbey , Chinonyerem Okoro , Jason Rothwax , Nabeel Shakir , Annerleim Walton-Diaz , Minhaj Siddiqui , Daniel Su , Lambros Stamatakis , Bradford J. Wood , Peter L. Choyke , Peter A. Pinto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 32, 2014 (suppl 4; abstr 128)
DOI
10.1200/jco.2014.32.4_suppl.128
Abstract #
128
Poster Bd #
H5
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
BPH-related false positive of 68Ga-PSMA PET/CT in the diagnosis of prostate cancer: The Achilles heel of biopsy-free radical prostatectomy?
First Author: Wei Tang
Poster
2022 ASCO Genitourinary Cancers Symposium
Salvage radiotherapy (SRT) in combination with pembrolizumab in patients with PSA persistence or biochemical recurrence after radical prostatectomy due to prostate cancer.
First Author: Markus Grabbert
Poster
2018 ASCO Annual Meeting
Neoadjuvant androgen deprivation therapy and enzalutamide: Imaging and pathological responses.
First Author: David James VanderWeele
Poster
2018 Genitourinary Cancers Symposium
Impact of genomic risk scores on treatment decisions following radical prostatectomy in a prospective Medicare registry.
First Author: John L. Gore